Robbie McLaren

Mr. McLaren's experience includes advising:

Life Sciences and Healthcare

• Norgine, a Netherlands-based specialty pharmaceutical company, in its US$2 billion sale to Goldman Sachs
• TPG on the acquisition of a majority interest in DOC Generici, a leading generic pharmaceutical company based in Milan, from ICG and Merieux Equity Partners
• Nordic Capital on the US$846 million acquisition of ADVANZ PHARMA, a specialty pharmaceutical company
• Eleusis, one of the leading psychedelics to medicine science companies, on its:
  • US$446 million merger with Silver Spike Acquisition Corp.
  • Acquisition of Kalypso TC, a provider of ketamine infusion therapies used to treat mental and physical conditions, such as major depressive disorder
• Abcam, a global leader in the supply of life science research tools on its US$340 million acquisition of BioVision
• BC Partners on the acquisition of a majority interest in the complex generic medicines business of Synthon International, a Netherlands-based multinational pharmaceutical company
• Atnahs Pharma (now Pharmanovia) on its acquisition of assets related to five hypertension medicine brands from AstraZeneca
• Acino on its acquisition of various pharmaceutical products and related assets in the NEMEA region from Takeda
• Apotex on the sale of two pharmaceutical products to Intas which are aimed at stimulating white blood cells during chemotherapy
• Baxter International Inc., in connection with its US$625 million acquisition of Claris Injectables Limited, an India-based manufacturer of sterile injectables
• Sienna Biopharmaceuticals in connection with its acquisition of Creabilis plc, a privately held specialty pharmaceutical company
• An Asian investor on their investment into Aerogen, an acute aerosol drug delivery business
• The shareholders of Pharmathen SA, a Greek pharmaceuticals company, on their sale of a controlling interest in Pharmathen to BC Partners
• Zogenix on its acquisition of Brabant Pharma, a UK-based pharmaceutical company
• Novo A/S in connection with the initial public offering of ADS on Nasdaq of Freeline Therapeutics
• Watson Pharmaceuticals / Actavis / Allergan on its:
  • €4.25 billion acquisition of the Actavis Group, making Watson the third largest global generics company
  • Divestment of part of its Western European generics sale and marketing business to Aurobindo
  • US$40.5 billion sale of its global generics pharmaceuticals business to Teva
• Theramex, a global specialty pharmaceutical company dedicated to women’s healthcare, in connection with its:
  • US$703 million acquisition by CVC Capital Partners of women’s healthcare assets from Teva Pharmaceutical Industries Ltd
  • Acquisition of certain pharmaceutical products from Janssen
  • Sale to a consortium controlled by Carlyle and PAI

Technology, Media, and Telecoms

• Rivulis, a portfolio company of Temasek, on the acquisition of the international irrigation business of Jain Irrigation Systems, an India-based micro irrigation systems company
• Darktrace plc in connection with its £1.7 billion initial public offering and listing on the London Stock Exchange
• The underwriters in connection with the £7.59 billion IPO of Deliveroo Holdings plc, listed on the London Stock Exchange
• Vertical Aerospace on its US$2.2 billion business combination with Broadstone Acquisition Corp., a special purpose acquisition company
• Centricus Acquisition Corp, a special purpose acquisition company, on its US$1 billion business combination with Arqit, a London-based developer of a quantum encryption platform
• Canva, an Australia-based online graphic design and publishing company, on its acquisition of Kiln Enterprises, a data visualization company
• Impact Holdings, Inc. on its acquisition of Trackonomics, a data management and digital marketing company
• Mimecast on the acquisition of Simply Migrate, a London-based provider of archive data migration technology
• Sony Pictures Entertainment and its subsidiary, Columbia Pictures Corporation, on the acquisition of Silvergate Media, a developer of children’s brands for broadcasters, streaming platforms, and retail partners (including the Octonauts, Peter Rabbit, and Hilda animated series)
• An Asian investor on their equity investment in:
  • Sound Cloud, a Germany-based company engaged in providing online audio platform services
  • Claroty, a cybersecurity software company
  • Common Sense Robotics
  • South pole
• Telenor on its €2.8 billion sale of its assets in Central and Eastern Europe (CEE) to PPF Group
• Netflix Inc. on the acquisition of Millarworld, a comic book company founded by Mark Millar
• Andreessen Horowitz on its minority investment in Improbable World Limited, a UK-based software developer focused on virtual and simulated worlds

Emerging Companies

• Moneybox, the leading digital wealth manager, on its £35 million Series D funding round
• Osler Diagnostics, a health technology company, on its Series C financing round
• Bloom and Wild on its:
  • Series C financing round
  • Acquisition of Bergamotte, a French online florist
  • Acquisition of Bloomon, a Netherlands-based online florist
• Carbon Clean, a global leader in cost-effective industrial carbon capture on the investment made by Chevron, one of the world’s leading integrated energy companies
• Novo Holdings on its:
  • £230 million disposal of Archimedes
  • US$800 million acquisition of Xellia
  • £400 million acquisition of BBI